THC BioMed Gets License to Produce Medical Marihuana

THC BioMed (CSE:THC) has been granted a license to produce medical marihuana under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).
As quoted in the press release:

Trading of THC.CSE was halted for one day this past Friday at the request of the company pending this announcement. Trading will resume as markets open on Monday, February 22.

THC President and CEO, John Miller, said:

We are filled with emotion and pride and take this opportunity to thank our dedicated shareholders for helping us get to this point. Now we look forward to providing the highest quality product to our customers and value to our shareholders as we work diligently to build a world class cannabis company.

Click here for the full press release.